Ivan Archilla
University of Barcelona
24 Papers
17 Citations
Ivan Archilla is an academic researcher from University of Barcelona. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 8 publications.
Chat about Author
Papers
GRP94 promotes brain metastasis by engaging pro-survival autophagy.
Naiara Santana-Codina,Laia Muixí,Ruben Foj,Rebeca Sanz-Pamplona,Miriam Badia-Villanueva,Agata Abramowicz,Anna Marcé-Grau,Ana M. Cosialls,Joan Gil,Ivan Archilla,Leire Pedrosa,Josep Maria Mesquida González,Iban Aldecoa,Angels Sierra +13 more
TL;DR: It is shown that GRP94 is directly implicated in BrM establishment by activating pro-survival autophagy, and disruption of this compensatory fueling route might prevent metastatic growth.
28
Lymph Node Tumor Burden Correlates With Tumor Budding and Poorly Differentiated Clusters: A New Prognostic Factor in Colorectal Carcinoma?
Ivan Archilla,Sherley Diaz-Mercedes,José Javier Aguirre,Jordi Tarragona,Isidro Machado,Maria Teresa Rodrigo,Sandra Lopez-Prades,Iñigo Gorostiaga,Stefania Landolfi,Begoña Otero Alén,Francesc Balaguer,Antoni Castells,Jordi Camps,Miriam Cuatrecasas +13 more
TL;DR: In this article, the authors evaluated the correlation between the total tumor load (TTL) in LNs from CRC surgical specimens with patient outcome, TB, and poorly differentiated clusters (PDCs) are associated with LN metastases, recurrences, and lower survival in CRC.
14
Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy.
Cristina Carrato,Francesc Alameda,Anna Esteve-Codina,Estela Pineda,Oriol Arpí,Maria Martinez-Garcia,Mar Mallo,Marta Gut,Raquel Lopez-Martos,Sonia Del Barco,Teresa Ribalta,Jaume Capellades,Josep Puig,Oscar Gallego,Carlos Mesia,Ana M. Muñoz-Mármol,Ivan Archilla,Montserrat Arumi,Julie Marie Blanc,Beatriz Bellosillo,Silvia Menendez,Anna Esteve,Silvia Bagué,Ainhoa Hernandez,Jordi Craven-Bartle,Rafael Fuentes,Noemi Vidal,Iban Aldecoa,Núria de la Iglesia,Carmen Balana +29 more
TL;DR: There is a subset of tumors, frequently classified as mesenchymal or IGS cluster 23, that may be identified with IHC and could well be optimal candidates for immunotherapy, especially with anti-M2 and/or dendritic cell vaccination.
10
Measles inclusion body encephalitis.
Iban Aldecoa,Ivan Archilla,Laura Herrero,Felipe García,Berta Torres,Carles Gaig,Sara Fernández,Maria Angeles Marcos,Ellen Gelpi +8 more
TL;DR: In this paper, the authors propose a method to solve the problem of homonymity of homophily in the context of homomorphic data, and no abstracts are available.
Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma.
Sherley Diaz-Mercedes,Ivan Archilla,Jordi Camps,A. Lacy,Iñigo Gorostiaga,Dulce Momblan,Ainitze Ibarzabal,Joan Maurel,Nuria Chic,Josep Antoni Bombí,Francesc Balaguer,Antoni Castells,Iban Aldecoa,Josep M. Borràs,Miriam Cuatrecasas +14 more
TL;DR: Introducing OSNA in CRC LN analysis may represent not only an economic benefit for the NHS but also a clinical benefit for CRC patients since a more accurate staging could be performed, thus avoiding unnecessary treatments.